Lymphoma Clinical Trials in Seattle

Showing 341-342 of 342 trials

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

NCT00039156

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BAY 59-8862 in treating patients who have refractory non-Hodgkin's lymphoma.

Lymphoma

TheradexStarted Jan 2002

Miami Beach, Florida, United States • Chicago, Illinois, United States • Shreveport, Louisiana, United States +12 more locations

COMPLETEDPhase 3307 miles

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00039910

Intensive chemotherapy is associated with significant thrombocytopenia, often requiring platelet transfusion to maintain platelet counts. This investigational drug has been demonstrated to increase platelet counts. This study will test the safety and efficacy of the investigational drug in the prevention of thrombocytopenia in patients with recurrent or refractory intermediate-grade or high-grade non-Burkitt's, non-Hodgkin's lymphoma (NHL), or Hodgkin's disease receiving DHAP (Dexamethasone, high-dose Cytarabine, and Cisplatin) chemotherapy.

Non-Hodgkin LymphomaHodgkin DiseaseThrombocytopenia

Pfizer240 participantsStarted Jul 2000

Phoenix, Arizona, United States • La Jolla, California, United States • Loma Linda, California, United States +35 more locations

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Lymphoma Trials in Other Cities

Other Conditions in Seattle